vs
Side-by-side financial comparison of Spero Therapeutics, Inc. (SPRO) and UNIVERSAL HEALTH REALTY INCOME TRUST (UHT). Click either name above to swap in a different company.
UNIVERSAL HEALTH REALTY INCOME TRUST is the larger business by last-quarter revenue ($24.5M vs $12.6M, roughly 1.9× Spero Therapeutics, Inc.). Spero Therapeutics, Inc. runs the higher net margin — 250.7% vs 17.7%, a 233.0% gap on every dollar of revenue. On growth, Spero Therapeutics, Inc. posted the faster year-over-year revenue change (24080.8% vs -0.7%). Over the past eight quarters, Spero Therapeutics, Inc.'s revenue compounded faster (847.7% CAGR vs -1.3%).
Universal Health Services, Inc. (UHS) is an American Fortune 500 company that provides hospital and healthcare services, based in King of Prussia, Pennsylvania. In 2024, UHS reported total revenues of $15.8 billion.
SPRO vs UHT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $12.6M | $24.5M |
| Net Profit | $31.5M | $4.3M |
| Gross Margin | — | — |
| Operating Margin | — | 34.7% |
| Net Margin | 250.7% | 17.7% |
| Revenue YoY | 24080.8% | -0.7% |
| Net Profit YoY | 250.9% | -7.2% |
| EPS (diluted) | $0.56 | $0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $12.6M | $24.5M | ||
| Q3 25 | $0 | $25.3M | ||
| Q2 25 | $0 | $24.9M | ||
| Q1 25 | $12.0K | $24.5M | ||
| Q4 24 | $52.0K | $24.6M | ||
| Q3 24 | $65.0K | $24.5M | ||
| Q2 24 | $114.0K | $24.7M | ||
| Q1 24 | $140.0K | $25.1M |
| Q4 25 | $31.5M | $4.3M | ||
| Q3 25 | $-7.4M | $4.0M | ||
| Q2 25 | $-1.7M | $4.5M | ||
| Q1 25 | $-13.9M | $4.8M | ||
| Q4 24 | — | $4.7M | ||
| Q3 24 | $-17.1M | $4.0M | ||
| Q2 24 | $-17.9M | $5.3M | ||
| Q1 24 | $-12.7M | $5.3M |
| Q4 25 | — | 34.7% | ||
| Q3 25 | — | 33.2% | ||
| Q2 25 | — | 35.6% | ||
| Q1 25 | -122758.3% | 36.8% | ||
| Q4 24 | — | 37.6% | ||
| Q3 24 | -28604.6% | 34.7% | ||
| Q2 24 | -16720.2% | 38.7% | ||
| Q1 24 | -9987.1% | 37.6% |
| Q4 25 | 250.7% | 17.7% | ||
| Q3 25 | — | 15.9% | ||
| Q2 25 | — | 18.1% | ||
| Q1 25 | -115550.0% | 19.5% | ||
| Q4 24 | — | 18.9% | ||
| Q3 24 | -26380.0% | 16.3% | ||
| Q2 24 | -15668.4% | 21.3% | ||
| Q1 24 | -9049.3% | 21.1% |
| Q4 25 | $0.56 | $0.32 | ||
| Q3 25 | $-0.13 | $0.29 | ||
| Q2 25 | $-0.03 | $0.32 | ||
| Q1 25 | $-0.25 | $0.34 | ||
| Q4 24 | — | $0.34 | ||
| Q3 24 | $-0.32 | $0.29 | ||
| Q2 24 | $-0.33 | $0.38 | ||
| Q1 24 | $-0.24 | $0.38 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $40.3M | $6.7M |
| Total DebtLower is stronger | — | $374.8M |
| Stockholders' EquityBook value | $59.0M | $152.4M |
| Total Assets | $68.9M | $564.9M |
| Debt / EquityLower = less leverage | — | 2.46× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $40.3M | $6.7M | ||
| Q3 25 | $48.6M | $6.9M | ||
| Q2 25 | $31.2M | $6.6M | ||
| Q1 25 | $48.9M | $7.0M | ||
| Q4 24 | $52.9M | $7.1M | ||
| Q3 24 | $76.3M | $6.4M | ||
| Q2 24 | $63.5M | $5.6M | ||
| Q1 24 | $82.3M | $7.7M |
| Q4 25 | — | $374.8M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $368.4M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $59.0M | $152.4M | ||
| Q3 25 | $26.5M | $158.6M | ||
| Q2 25 | $32.8M | $165.2M | ||
| Q1 25 | $33.8M | $172.2M | ||
| Q4 24 | $46.1M | $179.5M | ||
| Q3 24 | $65.5M | $181.6M | ||
| Q2 24 | $80.5M | $190.7M | ||
| Q1 24 | $96.2M | $196.5M |
| Q4 25 | $68.9M | $564.9M | ||
| Q3 25 | $54.2M | $568.0M | ||
| Q2 25 | $62.1M | $573.0M | ||
| Q1 25 | $77.7M | $573.5M | ||
| Q4 24 | $110.5M | $580.9M | ||
| Q3 24 | $135.2M | $584.3M | ||
| Q2 24 | $149.9M | $586.6M | ||
| Q1 24 | $167.7M | $596.2M |
| Q4 25 | — | 2.46× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 2.05× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-8.4M | $49.1M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | -0.26× | 11.35× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-8.4M | $49.1M | ||
| Q3 25 | $17.4M | $10.2M | ||
| Q2 25 | $-17.7M | $13.7M | ||
| Q1 25 | $-4.0M | $11.6M | ||
| Q4 24 | $-23.4M | $46.9M | ||
| Q3 24 | $12.8M | $9.9M | ||
| Q2 24 | $-18.7M | $12.1M | ||
| Q1 24 | $5.9M | $11.7M |
| Q4 25 | -0.26× | 11.35× | ||
| Q3 25 | — | 2.54× | ||
| Q2 25 | — | 3.05× | ||
| Q1 25 | — | 2.43× | ||
| Q4 24 | — | 10.06× | ||
| Q3 24 | — | 2.48× | ||
| Q2 24 | — | 2.30× | ||
| Q1 24 | — | 2.21× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SPRO
Segment breakdown not available.
UHT
| Reportable Segment Aggregation Before Other Operating Segment | $23.1M | 94% |
| Equity Method Investment Nonconsolidated Investee Or Group Of Investees | $2.3M | 9% |
